Enjoy complimentary customisation on priority with our Enterprise License!
The allergy relieving eye drops market size is forecast to increase by USD 373.2 million at a CAGR of 4.5% between 2023 and 2028.
The allergy relieving eye drops industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The market is primarily driven by the antihistamines segment due to its effectiveness in treating allergic conjunctivitis, a medical condition that causes itching, redness, and inflammation In the eyes. With the increasing prevalence of allergies and growing awareness of eye health, the demand for antihistamine-based drops is projected to increase significantly. Antihistamines function by inhibiting histamine release at H1 receptors, thereby alleviating symptoms such as itching, redness, swelling, and excessive tearing. Allergic reactions can be caused by various factors including pollen, environmental irritants, hormonal changes, and contact lenses. Other components of the market include mast cell stabilizers, corticosteroids, decongestant drops, and anti-inflammatory drops.
Symptoms of allergic conjunctivitis can also include pink or red eyes, burning sensations, stinging, and vision impairment. In cases of viral or bacterial conjunctivitis, medical help may be required, and nonprescription drops may not be effective. It is important to note that some drops, such as those containing decongestants or steroids, may not be suitable for individuals wearing contact lenses. Eye ointments and warm compresses may also be recommended for certain conditions. If you experience symptoms of allergic conjunctivitis, it is recommended to consult a healthcare professional for medical advice.
Get a glance at the market report of share of various segments Request Free Sample
The antihistamines segment was valued at USD 646.10 million in 2018 and showed a gradual increase during the forecast period.
Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market size of various regions, Request Free Sample
The market in North America holds the largest share due to increased R&D investments by pharmaceutical companies and a well-established regulatory framework for drug approvals. Approximately six million Americans are diagnosed with acute conjunctivitis annually. Allergy relieving drops are essential for managing symptoms of allergic conjunctivitis, including itching, redness, and inflammation. These drops contain various active ingredients, such as antihistamines, mast cell stabilizers, and anti-inflammatory agents. Over-the-counter options include ketotifen and artificial tears, while prescription drops may include corticosteroids, antibacterial, and anti-inflammatory agents.
Allergic reactions can also be caused by contact lenses, pollen season, viral or bacterial conjunctivitis, environmental irritants, autoimmune diseases, hormonal changes, and vitamin A deficiency. Symptoms may include itchiness, stinging, burning sensations, and vision impairment. Severe cases may require warm compresses, oral antibiotics, or prescription medications. It is crucial to consult medical help for proper diagnosis and treatment.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The high prevalence and incidence of eye infections is the key driver of the market.
The growing adoption of generics is the upcoming market trend.
Side effects associated with antibiotics is a key challenge affecting the industry growth.
The allergy relieving drops market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the allergy relieving drops market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, allergy relieving eye drops market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence In the industry.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Allergies affecting the eyes, also known as allergic conjunctivitis, can cause a range of uncomfortable symptoms. These symptoms include itching, redness, and inflammation of the eyes. Allergens, such as pollen, dust, or animal dander, can trigger these reactions. Allergic conjunctivitis can be managed with various types of eye drops. Two common categories of these drops are antihistamines and mast cell stabilizers. Antihistamines work by blocking the effects of histamines, which are chemicals released during an allergic reaction. Mast cell stabilizers, on the other hand, prevent the release of histamines and other inflammatory substances. Ketotifen is an example of a mast cell stabilizer used in eye drops.
Further, these drops are available both over-the-counter (OTC) and by prescription. The dosage varies depending on the specific product and individual needs. Allergic reactions can also lead to other symptoms, such as contact lens intolerance, pink or red eyes, and vision disturbances. In some cases, eye ointments or artificial tears may be recommended to provide additional relief. It is essential to note that some eye drops, such as decongestant eye drops and topical antihistamines, can have side effects and may not be suitable for long-term use. Corticosteroid eye drops, while effective in reducing inflammation, carry the risk of side effects and should only be used under medical supervision.
Allergic conjunctivitis can be caused by various factors, including environmental irritants, autoimmune diseases, hormonal changes, and vitamin A deficiency. In some cases, viral or bacterial infections can also cause symptoms similar to allergic conjunctivitis. Symptoms of allergic conjunctivitis can range from mild to severe. Mild cases may be managed with OTC eye drops, while more severe cases may require prescription medications. In some instances, warm compresses or oral antibiotics may be necessary to treat bacterial infections. It is important to remember that eye drops are not a substitute for medical help. If symptoms persist or worsen, individuals should consult a healthcare professional for proper diagnosis and treatment.
Market Scope |
|
Report Coverage |
Details |
Page number |
141 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.5% |
Market Growth 2024-2028 |
USD 373.2 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
4.23 |
Key countries |
US, Germany, UK, Canada, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
We can help! Our analysts can customize this allergy relieving eye drops market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.